AlbertKheradpourMD

Pediatric Hematology & Oncology • San Bernardino, CA

Assistant Professor, Pediatrics, Loma Linda University School of Medicine

Join to view full profile

Dr. Kheradpour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kheradpour's full profile

Already have an account?

Office
250 E Caroline St
Ste J
San Bernardino, CA 92408
Phone+1 909-558-4800

Fax+1 909-651-1933

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1991 - 1994
Atlantic Health System/Goryeb Children's HospitalResidency, Pediatrics, 1989 - 1991
Icahn School of Medicine at Mount Sinai (Jersey City)Internship, Pediatrics, 1988 - 1989
Tehran University of Medical Sciences School of MedicineClass of 1980

Certifications & Licensure

CA State Medical License 1992 - 2024
NJ State Medical License 1989 - 1999
TX State Medical License 1995 - 1999
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Start of enrollment: 2013 Jan 31
Completed
Phase 1, Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
Recruiting
Phase 3
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Active, not recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

25 citations
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal F...
David A. Jacobsohn, Michael R. Loken, Mingwei Fei, Alexia Adams, Lisa Eidenschink Brodersen
Biology of Blood and Marrow Transplantation. 2018-10-01
1 citations
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients.
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya
Ejhaem. 2024-02-01
6 citations
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen
Journal of Clinical Oncology. 2024-05-01